Watson Appeals Federal Court Ruling in Dispute Over Seasonique Patent

Watson Pharmaceuticals is appealing a federal court decision upholding the validity of Teva Pharmaceutical’s ’969 patent on Seasonique. The appeal, filed recently in the U.S. Court of Appeals for the Federal Circuit, follows a March 31 decision from the U.S. District Court for the District of Nevada granting Teva’s motion for summary judgment that its patent on the contraceptive is valid and enforceable.
Generic Line